Author

Imane Charmarke Askar

Observed names: Imane Charmarke-Askar, Imane Charmarké-Askar

Institutions: École Supérieure de Biotechnologie de Strasbourg, Université de Strasbourg

Observed institutions: Centre National de la Recherche Scientifique, Inserm, École Supérieure de Biotechnologie de Strasbourg, Biotechnologie et Signalisation Cellulaire, Université de Strasbourg

ORCID: 0009-0001-5574-5312

Observed ORCID: 0009-0001-5574-5312

OpenAlex ID: A5059624699

The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use

2022 · Dafni Birmpili, Imane Charmarke Askar, et al. · International Journal of Molecular Sciences · 30

Fluorinated apelin-13 mediates neuroprotective effects in multiple sclerosis models

2024 · Dafni Birmpili, Imane Charmarké-Askar, et al. · Neurobiology of Disease · 10

Implication of the Transmembrane Domain in the Interleukin 10 Receptor Platform Oligomerisation

2023 · Thomas Kuntzel, Caroline Spenlé, et al. · Cells · 3

Toward a Combination of Biomarkers for Molecular Characterization of Multiple Sclerosis

2022 · Dafni Birmpili, Imane Charmarke Askar, et al. · International Journal of Molecular Sciences · 2

narrowPASEF: A Sample-Aware diaPASEF Method Optimization Strategy Improving Differential Proteomics Performance on Low-Abundance Proteins

2026 · Jeewan Babu Rijal, Imane Charmarke Askar, et al. · Analytical Chemistry · 1

Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies

2024 · Imane Charmarke-Askar, Caroline Spenlé, et al. · Expert Opinion on Drug Discovery

De l’identification de la signature moléculaire de la SEP à la validation de l’effet thérapeutique de lumican dans un modèle d’encéphalomyélite autoimmune expérimentale

2024 · Imane Charmarke Askar · theses.fr (ABES)

Works count: 7

Citation count: 46

H-index: 3

I10-index: 2